Molecular determinants of glioma cell migration and invasion

Journal of Neurosurgery

Volumn 94, Issue 6, 2001, Pages 978-984

  Wild Bode, C ^a   Weller, M ^a   Wick, W ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Antiapoptotic protein; Brain neoplasm; Integrin; Tissue inhibitor of metalloproteinase 2

Indexed keywords

ALPHA INTEGRIN; BETA3 INTEGRIN; GELATINASE A; GELATINASE B; INTEGRIN; MESSENGER RNA; NEUTRALIZING ANTIBODY; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INFILTRATION; CANCER INVASION; CELL INVASION; CELL LINE; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; GLIOMA; HUMAN; HUMAN CELL; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034867240     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2001.94.6.0978     Document Type: Article

References (24)

1. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3
2. Accumulation of mutant p53(V143A) modulates the growth, clonogenicity, and radio-chemosensitivity of malignant glioma cells independent of endogenous p53 status
3. Matrix metalloproteinase- 2 activation modulates glioma cell migration
4. Glioma invasion in the central nervous system
5. 3 integrin. Adhesion mechanism for transformed glial cells
6. Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors
7. ECM-mediated glioma cell invasion
8. Growth and migration markers of rat C6 glioma cells identified by serial analysis of gene expression
9. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines
10. Adenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth
11. BAG-1 accelerates cell motility of human gastric cancer cells
12. 1 integrins
13. 3 integrin expression
14. Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies
15. p53 down-regulates human matrix metalloproteinase-1 (collagenase-1) gene expression
16. PTEN gene and integrin signaling in cancer
17. Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro
18. Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death
19. The role of integrins in the malignant phenotype of gliomas
20. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation
21. Predicting chemoresistance in human malignant glioma cells: The role of molecular genetic analysis
22. Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53
23. PTEN gene transfer in human malignant glioma: Sensitization to irradiation and CD95L-induced apoptosis
24. BCL-2 promotes migration and invasiveness of human glioma cells